Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cardiovascular diseases : from molecular pharmacology to evidence-based therapeutics / / Y. Robert Li
| Cardiovascular diseases : from molecular pharmacology to evidence-based therapeutics / / Y. Robert Li |
| Autore | Li Robert Y. |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons Inc., , 2015 |
| Descrizione fisica | 1 online resource (504 p.) |
| Disciplina | 616.1/061 |
| Soggetto topico |
Cardiovascular system - Diseases - Chemotherapy
Cardiovascular system - Diseases - Diagnosis |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-118-88994-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title Page; Copyright Page; Contents; Preface; List of Abbreviations; Unit I General Introduction; Chapter 1 Introduction to Cardiovascular Diseases; 1.1 Overview; 1.2 Definition of Cardiovascular Diseases; 1.3 Classification of Cardiovascular Diseases; 1.3.1 Classification Based on Anatomical Location; 1.3.2 Classification Based on the Involvement of Atherosclerosis; 1.3.3 Total Cardiovascular Diseases and ICD-10 Classification; 1.4 Prevalence, Incidence, and Trend of Cardiovascular Diseases; 1.4.1 NCDs and Cardiovascular Diseases: The Global Status
1.4.2 The Status of Cardiovascular Diseases in the United States1.4.3 The Status of Cardiovascular Diseases in China; 1.5 Risk Factors of Cardiovascular Diseases; 1.5.1 Classification of Cardiovascular Disease Risk Factors; 1.5.2 Major Cardiovascular Disease Risk Factors and Their Impact; 1.6 Prevention and Control of Cardiovascular Diseases; 1.6.1 The UN High-Level Meeting and Tackling Cardiovascular Diseases at the Global Level; 1.6.2 The World Heart Federation Call to Action to Prevent and Control Cardiovascular Diseases 1.6.3 The AHA 2010 Health Impact Goal, 2020 Health Impact Goal, and Ideal Cardiovascular Health1.6.4 US DHSS "Million Hearts" Initiative; 1.7 Cardiovascular Risk Prediction and Evidence-based Treatments; 1.7.1 Cardiovascular Risk Prediction; 1.7.2 Evidence-Based Treatments; 1.8 Summary of Chapter Key Points; 1.9 Self-Assessment Questions; References; Chapter 2 Introduction to Principles of Pharmacology; 2.1 Overview; 2.2 Definitions and History; 2.2.1 What Is Pharmacology?; 2.2.2 Definitions of Related Terms; 2.2.3 A Brief History of Pharmacology 2.3 Pharmacological Paradigm: the Central Dogma in Pharmacology2.3.1 Drug Names, Sources, Preparations, and Administration; 2.3.2 Pharmacokinetics; 2.3.3 Pharmacodynamics; 2.3.4 Drug Toxicity; 2.3.5 Pharmacogenetics and Pharmacogenomics; 2.4 Principles of Drug Discovery, Development, and Regulation; 2.4.1 Definitions; 2.4.2 The Paradigm of Drug Creation and Survival; 2.4.3 The FDA Drug Review and Approval Process; 2.5 Pharmacology Subspecialties; 2.6 Introduction to Cardiovascular Pharmacology; 2.6.1 Definition and Scope; 2.6.2 New Developments and Challenges 2.6.3 Systems Pharmacology in the Management of Cardiovascular Diseases2.6.4 Polypill for the Management of Cardiovascular Diseases; 2.6.5 Protein Therapeutics of Cardiovascular Diseases; 2.6.6 Gene Therapy of Cardiovascular Diseases; 2.6.7 Stem Cell Therapy of Cardiovascular Diseases; 2.7 Summary of Chapter Key Points; 2.8 Self-Assessment Questions; References; Unit II Dyslipidemias; Chapter 3 Overview of Dyslipidemias and Drug Therapy; 3.1 Introduction; 3.2 Lipoprotein Metabolism; 3.2.1 Definition, Structure, and Classification of Lipoproteins 3.2.2 Metabolic Pathways of Lipoproteins and Drug Therapy |
| Record Nr. | UNINA-9910460135303321 |
Li Robert Y.
|
||
| Hoboken, New Jersey : , : John Wiley & Sons Inc., , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular diseases : from molecular pharmacology to evidence-based therapeutics / / Y. Robert Li
| Cardiovascular diseases : from molecular pharmacology to evidence-based therapeutics / / Y. Robert Li |
| Autore | Li Robert Y. |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons Inc., , 2015 |
| Descrizione fisica | 1 online resource (504 pages) : illustrations (some color) |
| Disciplina | 616.1/061 |
| Soggetto topico |
Cardiovascular system - Diseases - Chemotherapy
Cardiovascular system - Diseases - Diagnosis |
| ISBN |
1-118-88994-0
1-118-88991-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910795975103321 |
|
Li Robert Y.
|
||
| Hoboken, New Jersey : , : John Wiley & Sons Inc., , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular diseases : from molecular pharmacology to evidence-based therapeutics / / Y. Robert Li
| Cardiovascular diseases : from molecular pharmacology to evidence-based therapeutics / / Y. Robert Li |
| Autore | Li Robert Y. |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons Inc., , 2015 |
| Descrizione fisica | 1 online resource (504 pages) : illustrations (some color) |
| Disciplina | 616.1/061 |
| Soggetto topico |
Cardiovascular system - Diseases - Chemotherapy
Cardiovascular system - Diseases - Diagnosis |
| ISBN |
1-118-88994-0
1-118-88991-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910819764403321 |
|
Li Robert Y.
|
||
| Hoboken, New Jersey : , : John Wiley & Sons Inc., , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||